HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Implementation of an interferon-gamma release assay to screen for tuberculosis in refugees and immigrants.

Abstract
Despite increased use and accuracy of interferon-gamma release assays to detect latent tuberculosis infection (LTBI) in foreign-born arrivals in the United States, risk characteristics associated with positive results are not well characterized. We conducted a retrospective record review of 541 refugees and immigrants screened for LTBI with QuantiFERON(®)-TB Gold In-Tube (QFT-IT) at the Spokane Public Health Clinic from January 2, 2008, through June 5, 2009. Overall, 24 % of the arrivals had a positive QFT-IT, with the greatest frequency of positive results occurring in arrivals from Liberia (100 %) and Bhutan (39 %). More than the expected number of Burmese had indeterminate QFT-IT results. A positive QFT-IT was associated with age, race, ethnicity, and extent of TB burden in the country of origin. QFT-IT is useful to screen for LTBI in foreign-born arrivals, particularly middle-aged adults from high-burden countries. However, the QFT-IT may not yield meaningful results in groups with significant immunocompromise.
AuthorsTerri Simpson, Julie Tomaro, Cynthia Jobb
JournalJournal of immigrant and minority health (J Immigr Minor Health) Vol. 15 Issue 4 Pg. 686-92 (Aug 2013) ISSN: 1557-1920 [Electronic] United States
PMID23179470 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Ambulatory Care Facilities
  • Bhutan
  • Child
  • Child, Preschool
  • Emigrants and Immigrants (statistics & numerical data)
  • Ethnicity
  • Female
  • Humans
  • Interferon-gamma Release Tests
  • Latent Tuberculosis (diagnosis, ethnology)
  • Liberia
  • Male
  • Mass Screening (methods)
  • Middle Aged
  • Myanmar
  • Refugees (statistics & numerical data)
  • Retrospective Studies
  • Risk Factors
  • Washington (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: